Medicare Enrolled

Dr. Gathline Etienne, MD

Neurology · Roswell, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2500 HOSPITAL BLVD STE 440, Roswell, GA 30076
7706634649
In practice since 2008 (18 years)
NPI: 1366602005 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Etienne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Etienne? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Etienne

Dr. Gathline Etienne is a neurology specialist in Roswell, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Etienne performed 13,365 Medicare services across 737 unique beneficiaries.

Between the years covered by Open Payments, Dr. Etienne received a total of $129,839 from 69 pharmaceutical and/or device companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Etienne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 8% volume in GA $129,839 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,365
Medicare services
Top 8% in GA for neurology
737
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~742 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
12,200 $5 $20
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
222 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
171 $87 $370
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
126 $0 $2
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
118 $10 $69
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
99 $57 $253
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
81 $114 $561
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
53 $112 $548
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
48 $44 $243
New patient office visit, complex (60-74 min) 45 $162 $705
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
40 $119 $496
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
40 $1 $6
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
34 $23 $128
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
28 $49 $255
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $101 $435
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
15 $61 $246
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
14 $28 $155
Eye deviation and range of motion exam
An examination to measure eye deviation and assess the range of motion of the eyes.
11 $42 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$129,839
Total received (2018-2024)
Avg $18,548/year across 7 years
Top 6% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
599
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$116,320 (89.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,464 (5.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,054 (4.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$62
2023
$11,574
2022
$29,487
2021
$36,376
2020
$42,152
2019
$8,536
2018
$1,652

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$62
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$29,641
Allergan, Inc.
$28,996
Biogen, Inc.
$26,522
AbbVie Inc.
$19,883
ABBVIE INC.
$17,737
ARGENX US, INC.
$1,206
Novartis Pharmaceuticals Corporation
$596
Allergan Inc.
$557
UCB, Inc.
$449
GENZYME CORPORATION
$292
Amgen Inc.
$277
Avanir Pharmaceuticals, Inc.
$263
SK Life Science, Inc.
$226
Teva Pharmaceuticals USA, Inc.
$193
Lundbeck LLC
$169
Greenwich Biosciences, Inc.
$160
Genentech USA, Inc.
$158
Lilly USA, LLC
$134
US WorldMeds, LLC
$133
ACADIA Pharmaceuticals Inc
$130
Harmony Biosciences LLC
$105
Bausch Health US, LLC
$104
Supernus Pharmaceuticals, Inc.
$102
Eisai Inc.
$100
Upsher-Smith Laboratories LLC
$100
Acorda Therapeutics, Inc
$94
AbbVie, Inc.
$90
Neurocrine Biosciences, Inc.
$81
Adamas Pharmaceuticals, Inc.
$75
Amneal Pharmaceuticals LLC
$73
Horizon Therapeutics plc
$69
EMD Serono, Inc.
$56
CSL Behring
$56
GE HEALTHCARE
$55
Takeda Pharmaceuticals U.S.A., Inc.
$51
Janssen Pharmaceuticals, Inc
$45
Grifols USA, LLC
$43
Egalet US Inc
$40
Promius Pharma LLC
$38
Zyla Life Sciences
$37
Endo Pharmaceuticals Inc.
$36
ASSERTIO THERAPEUTICS, Inc.
$35
Akcea Therapeutics, Inc.
$34
PFIZER INC.
$34
Neurelis, Inc.
$34
Vertical Pharmaceuticals, LLC
$34
ANI Pharmaceuticals, Inc.
$33
Sunovion Pharmaceuticals Inc.
$33
Mallinckrodt Enterprises LLC
$32
MDD US Operations, LLC
$31
Kyowa Kirin, Inc.
$31
BANNER LIFE SCIENCES, LLC
$27
Mallinckrodt LLC
$24
Scilex Pharmaceuticals Inc.
$23
Mallinckrodt Hospital Products Inc.
$22
Aprecia Pharmaceuticals, LLC
$22
Corium, LLC
$21
Biohaven Pharmaceutical Holding Company Ltd.
$20
W. L. Gore & Associates, Inc.
$19
Otsuka America Pharmaceutical, Inc.
$19
TG THERAPEUTICS, INC.
$18
JAZZ PHARMACEUTICALS INC.
$18
UPSHER-SMITH LABORATORIES LLC
$18
Shire North American Group Inc
$16
GRT US Holding, Inc.
$16
AstraZeneca Pharmaceuticals LP
$16
ARBOR PHARMACEUTICALS, INC.
$12
Almatica Pharma LLC
$12
EISAI INC.
$12
Top 3 companies account for 65.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · Cambia · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LUMIZYME · LYRICA · Leqembi · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · ONFI · ONZETRA Xsail · OSMOLEX ER · OXTELLAR XR · PAXLOVID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RYTARY · Rebif · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spritam · TECFIDERA · TEGSEDI · TEPEZZA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VYEPTI · VYVGART · Vimpat · WAINUA · Wakix · XCOPRI · Xadago · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in GA.

Looking for a neurology specialist in Roswell?
Compare neurologists in the Roswell area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
235
Per 100K population
22.0
County median income
$91,490
Nearest hospital
WELLSTAR NORTH FULTON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Etienne is a mixed practice specialist, with above-average Medicare volume (top 8% in GA), with speaking/promotional industry engagement in the top 6% of GA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Etienne experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Etienne performed 12,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Etienne receive payments from pharmaceutical companies?
Yes. Dr. Etienne received a total of $129,839 from 69 companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Etienne's costs compare to other neurologists in Roswell?
Dr. Etienne's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Etienne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →